Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Systematic review and meta-analysis of outcomes in solitary plasmacytomas finds patients with up to 10% BMPCs had reduced disease-free survival (15.7 vs. 79 mos); risks for shorter DFS included clonal marrow PCs and dFLC > 5 mg/dl.”
Authors: Charalampos Charalampous et al.
More posts featuring Robert Orlowski.
